Archived articles

Convalescent plasma

Convalescent plasma treatment may lower long COVID risk
Published Sept 20, 2023
Plasma from recovered patients, helpful in preventing severe COVID, could also decrease likelihood of post-COVID symptoms
Study suggests convalescent plasma may be safe COVID-19 treatment for high risk children
Published Feb 8, 2022
In a small study of 14 infants and children, convalescent plasma from patients who recovered from COVID-19 infection provided expected antibody levels and raised no safety concerns
Early dose of convalescent plasma may help COVID-19 patients avoid hospitalization
Published Jan 5, 2022
Nationwide, multicenter clinical trial led by Johns Hopkins shows convalescent plasma works as an early treatment for COVID-19, reducing need for hospitalization by 50%
COVID-19 treatment
Drop in convalescent plasma use linked to excess deaths
Published June 16, 2021
Study suggests the declining use of the COVID-19 therapy at U.S. hospitals from November 2020 to February 2021 may have led to more than 29,000 excess COVID-19 deaths
Severe COVID-19 patients may be best donors for convalescent plasma therapy
Published Oct 22, 2020
Study links stronger antibody responses to more severe disease, advanced age, and male sex
A 'healthy debate' on convalescent plasma
Published Sept 24, 2020
Hopkins immunologist Arturo Casadevall explains the different federal responses to the COVID-19 treatment and why it's normal to lack consensus in science / The Wall Street Journal
Convalescent plasma: A COVID-19 treatment speeds to clinical trials
Published July 28, 2020
An old-school approach offers a fast, stopgap solution for a modern pandemic